These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19817962)

  • 1. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.
    Oliveira CP; Stefano JT; Cavaleiro AM; Zanella Fortes MA; Vieira SM; Rodrigues Lima VM; Santos TE; Santos VN; de Azevedo Salgado AL; Parise ER; Ferreira Alves VA; Carrilho FJ; Corrêa-Giannella ML
    J Gastroenterol Hepatol; 2010 Feb; 25(2):357-61. PubMed ID: 19817962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease.
    Hashemi M; Hoseini H; Yaghmaei P; Moazeni-Roodi A; Bahari A; Hashemzehi N; Shafieipour S
    DNA Cell Biol; 2011 Aug; 30(8):569-75. PubMed ID: 21438662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
    Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
    Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.
    Jun DW; Han JH; Jang EC; Kim SH; Kim SH; Jo YJ; Park YS; Chae JD
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):667-72. PubMed ID: 19262398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
    Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis.
    Carulli L; Canedi I; Rondinella S; Lombardini S; Ganazzi D; Fargion S; De Palma M; Lonardo A; Ricchi M; Bertolotti M; Carulli N; Loria P
    Dig Liver Dis; 2009 Nov; 41(11):823-8. PubMed ID: 19403348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis.
    Namikawa C; Shu-Ping Z; Vyselaar JR; Nozaki Y; Nemoto Y; Ono M; Akisawa N; Saibara T; Hiroi M; Enzan H; Onishi S
    J Hepatol; 2004 May; 40(5):781-6. PubMed ID: 15094225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The glutamate-cysteine ligase catalytic subunit gene C-129T and modifier subunit gene G-23T polymorphisms and risk for coronary diseases].
    Zuo HP; Xu WJ; Luo M; Zhu ZZ; Zhu GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):637-40. PubMed ID: 17961430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis.
    Tokushige K; Takakura M; Tsuchiya-Matsushita N; Taniai M; Hashimoto E; Shiratori K
    J Hepatol; 2007 Jun; 46(6):1104-10. PubMed ID: 17395331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
    Sazci A; Ergul E; Aygun C; Akpinar G; Senturk O; Hulagu S
    Cell Biochem Funct; 2008 Apr; 26(3):291-6. PubMed ID: 17563923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients.
    Petit JM; Masson D; Minello A; Duvillard L; Galland F; Verges B; Gambert P; Hillon P
    Mol Genet Metab; 2006 Jun; 88(2):196-8. PubMed ID: 16458034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
    Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
    Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of CC16, OGG1 and GCLC polymorphisms and susceptibility to COPD.
    Liu S; Li B; Zhou Y; Zhong N; Ran P
    Respirology; 2007 Jan; 12(1):29-33. PubMed ID: 17207022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
    Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
    Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
    Zhan Q; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.
    Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A
    Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?
    Gambino R; Cassader M; Pagano G; Durazzo M; Musso G
    Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease?
    Machado MV; Martins A; Almeida R; Marques-Vidal P; Gonçalves MS; Camilo ME; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):201-5. PubMed ID: 19212208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.